Literature DB >> 19470744

Strain and virulence diversity in the mouse pathogen Chlamydia muridarum.

Kyle H Ramsey1, Ira M Sigar, Justin H Schripsema, Cecele J Denman, Anne K Bowlin, Garry A S Myers, Roger G Rank.   

Abstract

The mouse chlamydial pathogen Chlamydia muridarum has been used as a model organism for the study of human Chlamydia trachomatis urogenital and respiratory tract infections. To date, two commonly used C. muridarum isolates have been used interchangeably and are essentially taken to be identical. Herein, we present data that indicate that this is not the case. The C. muridarum Weiss isolate and C. muridarum Nigg isolate varied significantly in their virulences in vivo and possessed different growth characteristics in vitro. Distinct differences were observed in intravaginal 50% infectious doses and in challenge infections, with the Weiss isolate displaying greater virulence. Respiratory infection by the intranasal route also indicated a greater virulence of the Weiss isolate. In vitro, morphometric analysis revealed that the Weiss isolate produced consistently smaller inclusions in human cervical adenocarcinoma cells (HeLa 229) and smaller plaques in monolayers of mouse fibroblasts (L929) than did the Nigg isolate. In addition, the Weiss isolate possessed significantly higher replicative yields in vitro than did the Nigg isolate. In plaque-purified isolates derived from our stocks of these two strains, total genomic sequencing identified several unique nonsynonymous single nucleotide polymorphisms and insertion/deletion mutations when our Weiss (n = 4) and Nigg (n = 5) isolates were compared with the published Nigg sequence. In addition, the two isolates shared 11 mutations compared to the published Nigg sequence. These results prove that there is genotypic and virulence diversity among C. muridarum isolates. These findings can be exploited to determine factors related to chlamydial virulence and immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470744      PMCID: PMC2715693          DOI: 10.1128/IAI.00147-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  AN UNIDENTIFIED VIRUS WHICH PRODUCES PNEUMONIA AND SYSTEMIC INFECTION IN MICE.

Authors:  C Nigg
Journal:  Science       Date:  1942-01-09       Impact factor: 47.728

2.  Different growth rates of Chlamydia trachomatis biovars reflect pathotype.

Authors:  Isao Miyairi; Olaimatu S Mahdi; Scot P Ouellette; Robert J Belland; Gerald I Byrne
Journal:  J Infect Dis       Date:  2006-06-22       Impact factor: 5.226

3.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.

Authors:  K H Ramsey; T W Cotter; R D Salyer; G S Miranpuri; M A Yanez; C E Poulsen; J L DeWolfe; G I Byrne
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates.

Authors:  Harlan D Caldwell; Heidi Wood; Debbie Crane; Robin Bailey; Robert B Jones; David Mabey; Ian Maclean; Zeena Mohammed; Rosanna Peeling; Christine Roshick; Julius Schachter; Anthony W Solomon; Walter E Stamm; Robert J Suchland; Lacey Taylor; Sheila K West; Tom C Quinn; Robert J Belland; Grant McClarty
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

7.  A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis.

Authors:  A L Barron; H J White; R G Rank; B L Soloff; E B Moses
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

8.  Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis.

Authors:  K H Ramsey; W J Newhall; R G Rank
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

9.  Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations.

Authors:  Laszlo Kari; William M Whitmire; John H Carlson; Deborah D Crane; Nathalie Reveneau; David E Nelson; David C W Mabey; Robin L Bailey; Martin J Holland; Grant McClarty; Harlan D Caldwell
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

10.  ISOLATION FROM NORMAL MICE OF A PNEUMOTROPIC VIRUS WHICH FORMS ELEMENTARY BODIES.

Authors:  C Nigg; M D Eaton
Journal:  J Exp Med       Date:  1944-05-01       Impact factor: 14.307

View more
  41 in total

1.  Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis.

Authors:  Roger G Rank; Anne K Bowlin; Kati I Tormanen; Yin Wang; Anthony T Maurelli
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid.

Authors:  Marsha Russell; Toni Darville; Kumar Chandra-Kuntal; Bennett Smith; Charles W Andrews; Catherine M O'Connell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Mutational Analysis of the Chlamydia muridarum Plasticity Zone.

Authors:  Krithika Rajaram; Amanda M Giebel; Evelyn Toh; Shuai Hu; Jasmine H Newman; Sandra G Morrison; Laszlo Kari; Richard P Morrison; David E Nelson
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

4.  Host chemokine and cytokine response in the endocervix within the first developmental cycle of Chlamydia muridarum.

Authors:  Roger G Rank; H Marie Lacy; Anna Goodwin; James Sikes; Judy Whittimore; Priscilla B Wyrick; Uma M Nagarajan
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

5.  Mapping immunodominant antigens and H-2-linked antibody responses in mice urogenitally infected with Chlamydia muridarum.

Authors:  Hao Zeng; Shuping Hou; Siqi Gong; Xiaohua Dong; Quanming Zou; Guangming Zhong
Journal:  Microbes Infect       Date:  2012-03-03       Impact factor: 2.700

6.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

7.  Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Authors:  Gail L Sturdevant; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2014-04-10       Impact factor: 3.166

8.  Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.

Authors:  J H Kim; C Chan; C Elwell; M S Singer; T Dierks; H Lemjabbar-Alaoui; S D Rosen; J N Engel
Journal:  Cell Microbiol       Date:  2013-04-09       Impact factor: 3.715

9.  Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria.

Authors:  Kyla Frohlich; Ziyu Hua; Jin Wang; Li Shen
Journal:  J Microbiol Methods       Date:  2012-08-30       Impact factor: 2.363

10.  The Chromosome-Encoded Hypothetical Protein TC0668 Is an Upper Genital Tract Pathogenicity Factor of Chlamydia muridarum.

Authors:  Turner Allen Conrad; Siqi Gong; Zhangsheng Yang; Patrick Matulich; Jonathon Keck; Noah Beltrami; Chaoqun Chen; Zhou Zhou; Jin Dai; Guangming Zhong
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.